Approval · Notice of Compliance 21846 · 2019
AVELOX: Notice of Compliance 21846
Issued February 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21846
- Date
- February 11, 2019
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVELOX | Not yet assigned | — |
| AVELOX I.V. | Not yet assigned | — |
Medicinal ingredients
- MOXIFLOXACIN 400 MG per TAB
- MOXIFLOXACIN 400 MG per 250ML